Cervical Cancer Screening with VIA in Eastern Nepal - 3 Years Analysis



cervical cancer, cryotherapy, VIA


Aims: To estimate the VIA positivity rate and to see the efficacy of the treatment with cryotherapy during follow up.

Methods: A retrospective analysis of all VIA test from March 2012 to April 2015 were analyzed to estimate the VIA positivity rate of the screened population. Guideline for screening, treatment and follow up was as per the national guideline for cervical cancer screening and treatment 2010 of Nepal.

Results: A total of 12,444 clients were screened, the VIA positivity rate was 5.9%, repeat VIA positivity rate at the end of one year during follow up was 1.2%, more than 98% had been screened for cervical cancer for the first time and the complication following cryotherapy was low.

Conclusions: The VIA positivity rate of our population is comparable to the global magnitude. Screening for cervical cancer with VIA and treatment with cryotherapy is a feasible and acceptable form of screening in our setup. The recommendation would be scaling up of the facility up to grass root level that is linked to appropriate referral system.


Download data is not yet available.

Author Biographies

Pappu Rijal, BPKIHS

Department of Obstetrics and Gynaecology

A Agrawal, BPKIHS

Department of Obstetrics and Gynecology




How to Cite

Rijal, P., Chhetri, S., Agrawal, A., Pradhan, T., & Bhatta, R. (2018). Cervical Cancer Screening with VIA in Eastern Nepal - 3 Years Analysis. Nepal Journal of Obstetrics and Gynaecology, 12(2), 28–31. Retrieved from https://www.nepjol.info/index.php/NJOG/article/view/19945



Original Articles